India's Biocon falls on getting FDA observation for US site
ReutersOct 13, 2025 7:17 AM
** Biocon BION.NS falls 1.5% to 348 rupees; set to snap four-session gaining streak
** Biopharmaceutical co's U.S. manufacturing site in New Jersey's Cranbury gets one observation from U.S. FDA post inspection
** Cranbury site inaugurated last month
** Co says it will address observation within stipulated time; observation not expected to have any impact on business operations
** BION down ~5% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
U.S. Banks Q3 Earnings Preview: Big 5 Banks See Double-Digit EPS Growth, Investment Banking Hits 4-Year High
TradingKey - The 2025 U.S. earnings season kicks off this week with results from major banks. Amid elevated investor sentiment and the Trump administration pushing for deregulation, analysts expect another strong quarter for the banking sector — driven by booming trading activity and a resurgenceTradingKey
an hour ago
U.S.–China Tariff Easing Sparks Crypto Rebound — Can Bitcoin Reclaim Its Peak?
The U.S. signals a softer stance on tariffs, helping Bitcoin reverse losses. Rate cut expectations may push BTC back toward $126,000.TradingKey
2 hours ago
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
U.S. Government Shutdown Commentary: Is a Stock Market Crash Imminent? Will Gold Prices Continue to Surge?
TradingKey - On 1 October 2025, the U.S. federal government officially entered a shutdown, impacting various asset classes. This article analyses two key markets most affected—U.S. equities and gold—to help investors identify potential opportunities.TradingKey
Wed, Oct 1
Broadcom Q3 FY2025 Earnings Review: AI Surge and VMware Synergy Fuel Record Performance
TradingKey - Broadcom Inc. (NASDAQ: AVGO) delivered a strong fiscal Q3 2025, with results driven by AI networking strength and continued VMware integration. Revenue and EPS both topped expectations, reinforcing the company’s role as an essential player in the AI infrastructure buildout.TradingKey
Fri, Sep 5
